FDA issues updated guidance on adapting Covid-19 vaccines, tests and therapeutics for coronavirus variants
The US Food and Drug Administration has issued updated guidance for companies that plan to adapt their Covid-19 medical products — including vaccines, tests and therapeutics — to address the emergence of coronavirus variants. The agency said in an announcement on Monday that it expects that “manufacturing information will remain generally the same” for authorized
Continue Reading